tm aggregate reporting of pandemic influenza vaccine doses administered joint presentation by:...
TRANSCRIPT
TMTM
Aggregate Reporting of Pandemic Influenza Vaccine
Doses Administered
Joint Presentation by:
Immunization Services Division
National Center for Immunization and Respiratory Diseases and
Division of Emergency Preparedness and Response
National Center for Public Health Informatics
Webinar Presentation and Demonstration
To Public Health Project Areas
May 9, 2007
TMTM
Agenda
• Learning Objectives• Background• Aggregate Reporting Options and
Demonstration• State Vaccine Administration Tracking
Coordinator and Point of Contact Role • Timeline• CDC Resources• Questions and Answers
TMTM
Learning Objectives
• Understand the approaches and technologies available for reporting Pandemic Influenza vaccine aggregate doses administered to the CDC using the Countermeasure and Response Administration (CRA) system
• Understand the role and responsibilities required of the vaccine administration tracking point of contact CDC is requesting project areas identify (if not done already)
• Understand the timeline for testing the respective CRA option using seasonal influenza vaccine data as a proxy for pandemic influenza
• Understand the resources available to assist respective project areas in making the best fit option decision for reporting aggregate does administered using CRA to the CDC
TMTM
Background
• The National Pandemic Influenza Plan calls for monitoring of the appropriate use of a scarce pandemic influenza vaccine
• To accomplish this, states/ project areas will track vaccine doses administered and collect and aggregate minimum data elements and transmit weekly to CDC
• This webinar presents the range of approaches CDC has in place for states/project areas to provide the aggregate reporting required of the National Plan using CRA
TMTM
Example of Doses Administered Provider Record
TMTM
Options for Reporting to CDC
• Option 1: For states and partners collecting data via an existing immunization information system (IIS) or other application, technical specifications were developed for three different data exchange formats: pipe delimited, XML file, HL 7
• Option 2: For states and partners collecting data manually, an aggregate reporting screen was added to CDC’s CRA application to allow direct data entry via a web browser
• Option 3: For states and partners using CDC’s CRA application to collect patient level information, selected data elements will be automatically aggregated
TMTM
Option 1: Data Exchange
Summary of Option• Healthcare provider collects information locally and submits
selected data to the state IIS or other application• The state submits aggregate data to CDC’s CRA system on a
weekly basis via Immunization Information System or other application using one of three data exchange formats:• Pipe-delimited upload file• Extensible Markup Language (XML) file• Health Level 7 (HL7) Version 2.5
Process Considerations• What level of vaccination data and by whom it will be
collected must be determined; at minimum, core data elements must be collected
• Aggregate data exchange must be consolidated at the state or partner level prior to submission to CDC
TMTM
Option 1: Data Exchange (continued)
Technical Considerations• Local application should have capability to
collect core data elements• Core data elements should be extracted and
put into one of three formats following the Aggregate Reporting Guide: pipe-delimited, XML, HL7
• Transport mechanism should be determined and consistent with CDC PHIN standards
• Digital certificates should be in place for access and transfer to CRA
TMTM
Option 2: Direct Data Entry Via CRA Web Form
Summary of Option • Healthcare provider collects summarized data using the
Doses Administered Provider Record• Each week, the healthcare provider submits counts to
CDC via CRA’s web-based aggregate reporting user interface
Process Considerations• Determine who will enter information on-line
Technical Considerations• Staff entering data on-line must have access to the
internet via web browser• Staff accessing CRA must have a digital certificate
TMTM
Option 3: Calculate from CRA Detail Record
Summary of Option• Healthcare provider collects patient level information
locally using CDC’s CRA application• CRA automatically calculates counts from patient level
data entered
Process Considerations• Determine by whom and at what level of detail
vaccination data will be collected; CDC’s CRA can collect detailed individual level information in addition to core data elements
Technical Considerations• Staff entering data on-line must have access to the
internet via web browser• Staff accessing CRA must have a digital certificate
TMTM
Testing CRA Using Seasonal Influenza Vaccine Data as a
Proxy • Objective is to test the infrastructure for
reporting aggregate counts using seasonal influenza data beginning with the next influenza season - September 2007
• Test in at least one clinic within each project area jurisdiction
• Test using part(s) of CRA minimum data set applicable to seasonal influenza, i.e., age groups
• Regular reporting for influenza is for pandemic only; seasonal influenza reporting is for testing purposes only
TMTM
Summary of State POC for Vaccine Administration Tracking
• Communicate with CRA work group for updates and information exchange, training, and data interpretation, as needed
• Serve as lead for convening appropriate staff in the planning and operational aspects of how vaccine administered data will be collected and reported to the CRA
• Develop a plan for tracking vaccine doses administered that includes: • Helping gain access to at CDC-CRA grantee data and
obtain digital certificate.• Facilitating complete and timely local POD data collection
and submission to CRA• Timely collection, aggregation, and transmission to doses
administered data to CDC• Training of appropriate staff members
TMTM
Timeline on Aggregate Reporting
• May 15 : Identify POC • June : Determine option • June – Aug : Develop Plan • Jul – Oct : Technical
development
• Jul 07 – Apr 09 : Test CRA
TMTM
Dates and Tentative Topics of Future Webinars
• June 06 – Option 1 Discussion, Q&A
• July 11 – Options 2/3 Discussion, Q&A
• August 15 – Options 1/2/3 Q&A• Additional webinars and discussion
forums to be added
TMTM
Resources and Points of Contact• Toscha Stanley, Immunization Services Division (ISD),
[email protected]• Submit POC information
• Sanjeeb Sapkota, CRA Team, Division of Emergency Preparedness and Response, [email protected] • General aggregate reporting questions and inquiries
• PHIN E-mail [email protected]
• Issuing digital certificates• Getting access to CRA Exchange, an interactive knowledge
sharing and exchange web site (http://team.cdc.gov/)• Getting access to CRA demonstration site• Problem solving
• To get a copy of this presentation: http://www.cdc.gov/phin/preparedness/cra.html
TMTM
Learning Objectives
• Understand the approaches and technologies available for reporting Pandemic Influenza vaccine aggregate doses administered to the CDC using the Countermeasure and Response Administration (CRA) system
• Understand the role and responsibilities required of the vaccine administration tracking point of contact CDC is requesting project areas identify (if not done already)
• Understand the timeline for testing the respective CRA option using seasonal influenza vaccine data as a proxy for pandemic influenza
• Understand the resources available to assist respective project areas in making the best fit option decision for reporting aggregate does administered using CRA to the CDC
TMTM
Questions?